[Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
D000499:Allylamine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000588:Amines / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003022:Clotrimazole / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008864:Microsporum; D009824:Ointments; D011897:Random Allocation; D014005:Tinea / Q000188:drug therapy*; D014047:Tolnaftate / Q000627:therapeutic use*; D014249:Trichophyton
D000588:Amines; D000935:Antifungal Agents; D007093:Imidazoles; D009824:Ointments; D014047:Tolnaftate; D000499:Allylamine; C029178:naftifine; D003022:Clotrimazole
Doppelblinde, randomisierte vergleichende in vivo Untersuchungen zwischen den Antimykotika Clotrimazol, Tolnaftat und Naftifin.